학술논문
Efficacy and safety of the first-in-class imidazoline-2 receptor ligand CR4056 in pain from knee osteoarthritis and disease phenotypes: a randomized, double-blind, placebo-controlled phase 2 trial
Document Type
Article
Author
Source
In Osteoarthritis and Cartilage January 2020 28(1):22-30
Subject
Language
ISSN
1063-4584